Search

everythinglearnresearchcommunity

for

Search:↓

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Tamoxifen caused hair loss in a 52-year-old woman.

Vitamin A is important for healthy skin and hair, influencing hair growth and skin healing, but UV light reduces its levels.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

FUE hair transplant is a promising method with benefits like less scarring, but requires a skilled surgeon and can damage hair follicles.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

The pumpkin seed oil niosomes are promising for skin and hair treatments because they are stable and effectively deliver the oil.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

High mTORC1 activity slows hair growth and causes it to lose color.

The protein EZH2 blocks microRNA-22, increasing STK40 protein, which helps hair follicle stem cells change and grow hair.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

PRP and cell therapies may help with hair loss, but more research is needed.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Various treatments exist for hair loss, but more research is needed for better options.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Using minoxidil before and after facelift surgery can effectively prevent temporary hair loss without causing other complications.

The Bcl-2 protein is important for keeping hair follicle stem cells working and preventing hair loss.

MicroRNAs are important for hair growth regulation, with Dicer being crucial and Tarbp2 less significant.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

Taxol damages hair growth cells, causing hair loss.